Twist Bioscience Corporation (TWST) Q3 2019 Earnings Results

Twist Bioscience Misses on EPS, Stock Down 3.8%

The earnings report indicates challenges for Twist Bioscience, particularly with the lack of revenue figures and guidance. The stock fell 3.8% as investors reacted to the uncertainty surrounding the company's financial outlook. Without clear metrics or future expectations, investor confidence may be shaken.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-0.92	N/A	N/A
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Defensive

Management expressed a cautious approach due to the current market conditions. They emphasized the importance of innovation and strategic investments.

Management did not provide specific revenue figures or guidance for the upcoming quarters.

The focus remains on long-term growth and product development.

Twist Bioscience Misses on EPS, Stock Down 3.8%

Key numbers

Management commentary

Twist Bioscience Corporation

More earnings this week

Twist Bioscience Misses on EPS, Stock Down 3.8%

Key numbers

Management commentary